ArticleBMC urology2022

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas.

Jiale Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.